Basel, Switzerland

Maria Caterina Testa



 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Caterina Testa: Innovator in Pharmaceutical Manufacturing

Introduction

Maria Caterina Testa is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical manufacturing, holding 2 patents that showcase her innovative spirit and expertise.

Latest Patents

Her latest patents include a process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine. This invention discloses improved processes for manufacturing the compound, its monohydrochloride salt, and intermediates thereof. Another notable patent is related to the manufacturing process for pyrimidine derivatives. This invention pertains to processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer, or a salt thereof, with specific substituents defined in the specification. It further relates to new manufacturing processes for specific solid forms of Compound A and its salts, as well as their therapeutic applications for warm-blooded animals.

Career Highlights

Maria Caterina Testa is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative solutions in drug manufacturing and development.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as Dietmar Flubacher and Pascal Michel. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Maria Caterina Testa exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and work at Novartis AG highlight her commitment to improving drug manufacturing processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…